title: Impact of immunosuppression and acute rejection on hepatitis B recurrence.
authors.affiliation: Department of Surgery, Virchow Clinic, Humboldt University Berlin, Germany.
authors.forename: K P
authors.initials: KP
authors.lastname: Platz
authors.forename: A R
authors.initials: AR
authors.lastname: Mueller
authors.forename: G W
authors.initials: GW
authors.lastname: Haller
authors.forename: T
authors.initials: T
authors.lastname: Berg
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: U
authors.initials: U
authors.lastname: Hopf
authors.forename: H
authors.initials: H
authors.lastname: Lobeck
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology*; D006085:Graft Survival; D006509:Hepatitis B / Q000276:immunology* / Q000601:surgery* / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; C045213:hepatitis B hyperimmune globulin